Sign in

CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
  1. 4 Grant or award Director acquired 1,045 shares (grant or award)
  2. 4 Grant or award Director acquired 1,045 shares (grant or award)
  3. 4 Grant or award Director acquired 1,045 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 6,730 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award SrVP/CFO/Prin Fin & Acct Ofcr acquired 3,365 shares (grant or award)
  7. 4 Grant or award President, CEO acquired 6,725 shares (grant or award)
  8. 4 Open-market buy SrVP/CFO/Prin Fin & Acct Ofcr bought 1,010 shares at $7.29 ($7,363)
  9. 4 Open-market buy Director bought 6,860 shares at $7.29 ($50,009)
  10. 4 Open-market buy Director bought 6,860 shares at $7.29 ($50,009)
  11. 4 Open-market buy President, CEO bought 2,000 shares at $7.29 ($14,580)
  12. 4 Grant or award Director acquired 500 shares (grant or award)
  13. 4 Grant or award Director acquired 500 shares (grant or award)
  14. 4 Grant or award Director acquired 500 shares (grant or award)
  15. 4 Grant or award Director acquired 500 shares (grant or award)
  16. 4 Grant or award Director acquired 500 shares (grant or award)
  17. 4 Grant or award Director acquired 500 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy Director bought 10,097 shares at an average $3.66 ($36,957)

Page 3 of 9 · 180 filings